Skip to main content

Table 1 The remaining CDDP and pH increase in a time-dependent manner under each shading condition

From: Effect of different shielding conditions on the stability of Cisplatin

Shading condition

CDDP Conc.

Storage time (h)

0

3

6

24

48

72

96

120

Al

250 μg/mL

100 ± 0.0 (3.91 ± 0.05)

101.7 ± 1.1 (3.92 ± 0.04)

102.5 ± 1.2 (3.89 ± 0.02)

101.5 ± 1.4 (3.76 ± 0.11)

101.9 ± 1.7 (3.92 ± 0.08)

101.1 ± 1.2 (3.90 ± 0.11)

101.5 ± 2.0 (3.91 ± 0.07)

101.0 ± 1.0 (3.85 ± 0.07)

100 μg/mL

100 ± 0.0 (4.30 ± 0.06)

101 ± 1.2 (4.31 ± 0.04)

101.8 ± 1.8 (4.30 ± 0.01)

100.3 ± 2.7 (4.19 ± 0.09)

101.8 ± 1.6 (4.32 ± 0.06)

100.8 ± 2.8 (4.31 ± 0.09)

101.6 ± 1.5 (4.26 ± 0.12)

100.6 ± 2.9 (4.27 ± 0.03)

50 μg/mL

100 ± 0.0 (4.60 ± 0.03)

102.2 ± 0.7 (4.61 ± 0.03)

100.8 ± 0.3 (4.61 ± 0.02)

102.0 ± 1.4 (4.52 ± 0.12)

100.0 ± 0.4 (4.62 ± 0.08)

101.2 ± 2.3 (4.59 ± 0.10)

101.5 ± 1.2 (4.63 ± 0.05)

100.9 ± 2.3 (4.61 ± 0.01)

BSC

250 μg/mL

100 ± 0.0 (3.91 ± 0.06)

100.6 ± 0.5 (3.93 ± 0.04)

100.3 ± 0.2 (3.90 ± 0.02)

99.4 ± 2.0 (3.79 ± 0.17)

100.2 ± 0.2 (3.91 ± 0.11)

100 ± 0.6 (3.91 ± 0.10)

99.8 ± 0.5 (3.92 ± 0.06)

99.3 ± 1.4 (3.88 ± 0.07)

100 μg/mL

100 ± 0.0 (4.30 ± 0.05)

101.2 ± 0.4 (4.29 ± 0.05)

102.2 ± 0.7 (4.30 ± 0.01)

101.1 ± 0.1 (4.18 ± 0.10)

100.6 ± 1.2 (4.32 ± 0.08)

101.8 ± 0.8 (4.29 ± 0.09)

100.8 ± 0.8 (4.30 ± 0.09)

100.8 ± 1.9 (4.32 ± 0.03)

50 μg/mL

100 ± 0.0 (4.61 ± 0.04)

99.7 ± 1.6 (4.60 ± 0.04)

100.3 ± 1.2 (4.62 ± 0.02)

100.4 ± 1.8 (4.51 ± 0.13)

100.4 ± 2.6 (4.64 ± 0.07)

101.1 ± 2.9 (4.59 ± 0.11)

100.8 ± 1.3 (4.63 ± 0.08)

97.5 ± 1.4 (4.65 ± 0.01)

YSC

250 μg/mL

100 ± 0.0 (3.91 ± 0.05)

102.2 ± 1.0 (3.92 ± 0.04)

101.0 ± 1.0 (3.91 ± 0.01)

100.2 ± 1.9 (3.79 ± 0.16)

100.0 ± 2.2 (3.95 ± 0.06)

100.7 ± 1.8 (3.95 ± 0.09)

100.2 ± 2.2 (3.92 ± 0.08)

100.2 ± 2.9 (3.94 ± 0.06)

100 μg/mL

100 ± 0.0 (4.31 ± 0.04)

101.4 ± 0.7 (4.31 ± 0.05)

101.5 ± 0.8 (4.30 ± 0.02)

99.7 ± 1.1 (4.20 ± 0.13)

101.0 ± 0.4 (4.31 ± 0.09)

100.1 ± 0.9 (4.33 ± 0.10)

99.9 ± 0.1 (4.38 ± 0.10)

100.9 ± 1.0 (4.36 ± 0.04)

50 μg/mL

100 ± 0.0 (4.62 ± 0.03)

99.9 ± 1.1 (4.60 ± 0.03)

99.0 ± 1.4 (4.62 ± 0.02)

98.6 ± 2.1 (4.51 ± 0.14)

97.8 ± 1.1 (4.64 ± 0.06)

98.8 ± 3.1 (4.64 ± 0.09)

98.1 ± 2.0 (4.63 ± 0.10)

97.6 ± 1.0 (4.66 ± 0.02)

MAC

250 μg/mL

100 ± 0.0 (3.91 ± 0.03)

100.2 ± 0.8 (3.96 ± 0.04)

99.3 ± 2.0 (3.95 ± 0.01)

94.3 ± 2.0 (4.06 ± 0.19)

a88.9 ± 1.3 (4.77 ± 0.12)

a82.9 ± 1.4 (5.97 ± 0.21)

b76.0 ± 2.0 (6.50 ± 0.17)

b70.8 ± 1.3 (6.85 ± 0.09)

100 μg/mL

100 ± 0.0 (4.30 ± 0.03)

100.8 ± 1.6 (4.35 ± 0.04)

99.0 ± 1.4 (4.35 ± 0.03)

95.0 ± 1.8 (4.52 ± 0.18)

a87.9 ± 1.8 (5.23 ± 0.08)

a83.6 ± 1.4 (6.04 ± 0.12)

b76.8 ± 2.0 (6.50 ± 0.03)

b70.0 ± 2.7 (6.77 ± 0.05)

50 μg/mL

100 ± 0.0 (4.63 ± 0.02)

100.4 ± 1.2 (4.63 ± 0.04)

98.5 ± 0.6 (4.67 ± 0.03)

94.6 ± 2.4 (4.77 ± 0.14)

a89.7 ± 1.8 (5.33 ± 0.09)

a83.6 ± 1.8 (5.91 ± 0.15)

b76.6 ± 4.0 (6.32 ± 0.06)

b71.5 ± 2.9 (6.54 ± 0.03)

NSC

250 μg/mL

100 ± 0.0 (3.94 ± 0.05)

100.2 ± 2.0 (3.96 ± 0.06)

98.6 ± 1.6 (3.96 ± 0.02)

94.7 ± 1.2 (4.11 ± 0.21)

a85.3 ± 4.5 (4.86 ± 0.23)

a82.4 ± 1.4 (6.25 ± 0.21)

b75.0 ± 1.0 (6.84 ± 0.07)

c68.7 ± 0.4 (7.11 ± 0.11)

100 μg/mL

100 ± 0.0 (4.31 ± 0.02)

99.9 ± 1.1 (4.36 ± 0.02)

98.3 ± 1.4 (4.36 ± 0.03)

92.6 ± 1.1 (4.53 ± 0.13)

a84.0 ± 5.7 (5.31 ± 0.12)

a81.3 ± 0.4 (6.21 ± 0.14)

b74.9 ± 1.5 (6.60 ± 0.21)

c68.9 ± 1.9 (6.83 ± 0.05)

50 μg/mL

100 ± 0.0 (4.61 ± 0.06)

102.1 ± 2.3 (4.66 ± 0.03)

98.3 ± 1.3 (4.68 ± 0.03)

93.8 ± 1.5 (4.79 ± 0.08)

a86.2 ± 3.8 (5.40 ± 0.11)

a83.1 ± 2.5 (6.03 ± 0.18)

b77.4 ± 0.6 (6.39 ± 0.02)

c69.2 ± 2.3 (6.63 ± 0.03)

  1. Data of the remaining CDDP (pH increase) represent the mean with SD of three independent samples. a < 90%, b < 80%, and c < 70% shows the remaining CDDP compared to 0 h data. Al: aluminum foil, BSC brown shading cover, YSC yellow shading cover, MAC milky-white anti-exposure cover, and NSC no shading cover